What is the appropriate management for ocular involvement in a patient with Stevens‑Johnson syndrome who cannot open the eye and has a subconjunctival hemorrhage?

Management of Ocular Involvement in SJS with Inability to Open Eye and Subconjunctival Hemorrhage

This patient requires immediate daily ophthalmological assessment with aggressive topical therapy including preservative-free lubricants every 2 hours, topical corticosteroids (dexamethasone 0.1% twice daily), and prophylactic broad-spectrum antibiotics (moxifloxacin four times daily), combined with meticulous daily ocular hygiene by an ophthalmologist or trained nurse to prevent vision-threatening complications. 1

Immediate Ophthalmological Management

The inability to open the eye in SJS represents significant acute ocular involvement that demands urgent intervention. The subconjunctival hemorrhage, while concerning, is less critical than the underlying inflammatory process that threatens long-term vision.

Daily Ophthalmological Review

• Mandatory daily examination by an ophthalmologist throughout the acute illness 1
• This is non-negotiable regardless of apparent severity, as 74% of SJS/TEN patients develop ocular involvement, and importantly, the severity of acute ocular disease does NOT predict late complications 1
• Up to 50-63% of patients with acute involvement develop chronic sequelae including severe dry eyes, trichiasis, and limbal stem cell deficiency 1

Topical Therapy Protocol

Ocular Lubrication:

• Apply preservative-free hyaluronate or carmellose eye drops every 2 hours throughout acute illness 1
• Preservatives are deleterious to the already compromised ocular surface and must be avoided 2

Topical Corticosteroids:

• Preservative-free dexamethasone 0.1% twice daily to reduce ocular surface damage 1
• While the role of topical corticosteroids remains somewhat controversial in the literature 2, UK guidelines provide clear recommendations for their use to ameliorate conjunctival inflammation 1

Prophylactic Antibiotics:

• Broad-spectrum topical antibiotic (moxifloxacin drops four times daily) in the presence of corneal fluorescein staining or frank ulceration 1
• Given the inability to open the eye, assume corneal compromise exists and initiate prophylaxis

Vitamin A Ointment:

• Applied regularly (90% of French reference centers use this) 2

Critical Daily Ocular Hygiene

Daily ocular hygiene must be performed by an ophthalmologist or ophthalmically trained nurse 1. This involves:

• Removal of pseudomembranes (performed by 90% of specialized centers) 2
• Prevention and management of conjunctival adhesions (symblepharon formation)
• Assessment for corneal exposure, ulceration, and infection

Prevention of Corneal Exposure

In patients who cannot open their eyes or are semiconscious, prevention of corneal exposure is essential 1. This may require:

• Frequent lubrication
• Consideration of symblepharon rings (used in 55% of specialized centers when necessary) 2
• Protective measures to maintain corneal integrity

Advanced Interventions

Amniotic Membrane Transplantation (AMT)

• Consider early AMT for severe acute involvement, though it should not be performed systematically 2
• Recent evidence suggests early AMT may prevent long-term complications and shows promise in controlling acute inflammation 3, 4
• Decision should be made on a case-by-case basis according to clinical course 2

Systemic Considerations

• Systemic corticosteroid therapy for ophthalmologic indication is occasionally used (33% of centers) and discussed case-by-case 2
• Recent protocols including early pulse systemic steroids have shown positive effects on ocular outcomes 5

Critical Pitfalls to Avoid

1. Do not assume mild acute involvement means good prognosis: Neither systemic disease severity nor acute ocular grade predicts late complications 1

2. Avoid preserved eye drops: Preservatives worsen ocular surface damage in already compromised eyes 2

3. Do not delay ophthalmology consultation: Immediate involvement is required, as effective management demands minimization of destructive ocular surface and lid margin inflammation 1

4. Do not neglect long-term follow-up: Late complications may not become apparent until weeks or months after the acute episode, requiring appropriate long-term ophthalmological follow-up arrangements 1

Multidisciplinary Coordination

This patient requires management within an SJS/TEN multidisciplinary team (MDT) that includes ophthalmology with a defined management plan 6. Transfer to a center with experience managing SJS/TEN should be considered, particularly if body surface area involvement exceeds 10% or comorbidities exist 6.

The subconjunctival hemorrhage itself requires no specific treatment but serves as a marker of the severity of ocular inflammation. The priority is preventing the devastating long-term sequelae of ocular SJS/TEN through aggressive acute-phase management.